Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

1,144.176
+37.8453.42%
Number of Gainers:16
Number of Losers:1
Number of Flat:1
PE:- -
High:1,148.964
Open:1,106.049
Low:1,097.950
Close:1,106.332
Volume:507.71M
Turnover:3.97B
Market Cap:771.53B
Float Cap:642.71B

Loading ...

TYK MEDICINES-B to Present Findings from Five Novel Drug Programs at 2026 AACR Conference

Stock News
·
Mar 25

Truking Technology's Subsidiary Focuses on Robotics in Pharmaceutical and Adjacent Sectors

Deep News
·
Mar 25

FOSUN PHARMA Reports 2025 Results: Revenue Hits 41.7B Yuan with 21.7% Net Profit Growth

Deep News
·
Mar 25

CSPC PHARMA (01093) Approves 2026 Share Award Scheme

Stock News
·
Mar 25

CSPC Pharmaceutical adopts 2026 share award scheme; scheme limit climbs to 3% of issued shares

Reuters
·
Mar 25

Hong Kong Stocks Extend Gains Wednesday; Pop Mart, CSPC Earnings Miss Estimates

MT Newswires Live
·
Mar 25

JD Health International Stock Advances 1.7% in Hong Kong

Dow Jones
·
Mar 25

CSPC Pharmaceutical Group Stock Climbs 1.9% in Hong Kong, Outperforms Competitors

Dow Jones
·
Mar 25

BYD Electronic (International) Stock Climbs 3.3% in Hong Kong

Dow Jones
·
Mar 25

Alibaba Health Information Technology Stock Climbs 2.7% in Hong Kong

Dow Jones
·
Mar 25

AH Share Premium Rankings for March 25

Stock News
·
Mar 25

Ping An Healthcare Unit Enters Services Deal With Parent Ping An

MT Newswires Live
·
Mar 25

PA GOODDOCTOR Strengthens Post-Independence Shift

Deep News
·
Mar 25

JUNSHI BIO Sees 28% Revenue Growth, Yet Struggles to Close Nearly 10-Billion-Yuan Loss Gap

Deep News
·
Mar 25

HENLIUS: Earnings Exceed Expectations, Pipeline and Performance Set for Dual Gains

Deep News
·
Mar 25

CSPC PHARMA to Distribute Final Dividend of HKD 0.15 Per Share on July 15

Stock News
·
Mar 25

BRIEF-CSPC Pharmaceutical Logs FY Net Income Attributable RMB 3,882.1 Mln

Reuters
·
Mar 25

CSPC Pharmaceutical Group proposes final dividend of HKD 0.15 per share for FY2025

Reuters
·
Mar 25

CSPC Pharmaceutical Group FY Net Income Attributable RMB 3,882.1 Million

THOMSON REUTERS
·
Mar 25

CSPC Pharmaceutical Group FY Revenue RMB 20,583.7 Million

THOMSON REUTERS
·
Mar 25